Logo image of CENX

CENTURY ALUMINUM COMPANY (CENX) Stock Fundamental Analysis

NASDAQ:CENX - Nasdaq - US1564311082 - Common Stock - Currency: USD

20.32  -0.39 (-1.88%)

After market: 20.77 +0.45 (+2.21%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CENX. CENX was compared to 154 industry peers in the Metals & Mining industry. There are concerns on the financial health of CENX while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on CENX.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CENX was profitable.
In the past year CENX had a positive cash flow from operations.
In the past 5 years CENX reported 4 times negative net income.
In multiple years CENX reported negative operating cash flow during the last 5 years.
CENX Yearly Net Income VS EBIT VS OCF VS FCFCENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

With a decent Return On Assets value of 5.80%, CENX is doing good in the industry, outperforming 78.57% of the companies in the same industry.
CENX's Return On Equity of 15.60% is amongst the best of the industry. CENX outperforms 88.96% of its industry peers.
With a decent Return On Invested Capital value of 8.64%, CENX is doing good in the industry, outperforming 79.22% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CENX is significantly below the industry average of 11.67%.
The last Return On Invested Capital (8.64%) for CENX is above the 3 year average (3.18%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.8%
ROE 15.6%
ROIC 8.64%
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
CENX Yearly ROA, ROE, ROICCENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CENX has a Profit Margin of 4.79%. This is in the better half of the industry: CENX outperforms 70.13% of its industry peers.
CENX has a better Operating Margin (7.00%) than 60.39% of its industry peers.
CENX's Operating Margin has improved in the last couple of years.
The Gross Margin of CENX (9.69%) is comparable to the rest of the industry.
CENX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7%
PM (TTM) 4.79%
GM 9.69%
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
CENX Yearly Profit, Operating, Gross MarginsCENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CENX is destroying value.
Compared to 1 year ago, CENX has more shares outstanding
The number of shares outstanding for CENX has been increased compared to 5 years ago.
Compared to 1 year ago, CENX has a worse debt to assets ratio.
CENX Yearly Shares OutstandingCENX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CENX Yearly Total Debt VS Total AssetsCENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CENX has an Altman-Z score of 1.47. This is a bad value and indicates that CENX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.47, CENX is doing worse than 68.83% of the companies in the same industry.
CENX has a Debt/Equity ratio of 0.64. This is a neutral value indicating CENX is somewhat dependend on debt financing.
CENX has a worse Debt to Equity ratio (0.64) than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACC0.87
WACC9.94%
CENX Yearly LT Debt VS Equity VS FCFCENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CENX has a Current Ratio of 1.84. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.84, CENX is not doing good in the industry: 62.99% of the companies in the same industry are doing better.
CENX has a Quick Ratio of 1.84. This is a bad value and indicates that CENX is not financially healthy enough and could expect problems in meeting its short term obligations.
CENX has a worse Quick ratio (0.63) than 85.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 0.63
CENX Yearly Current Assets VS Current LiabilitesCENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 282.05% over the past year.
Looking at the last year, CENX shows a quite strong growth in Revenue. The Revenue has grown by 11.41% in the last year.
CENX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.87% yearly.
EPS 1Y (TTM)282.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1300%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%29.5%

3.2 Future

The Earnings Per Share is expected to grow by 62.41% on average over the next years. This is a very strong growth
Based on estimates for the next years, CENX will show a quite strong growth in Revenue. The Revenue will grow by 10.44% on average per year.
EPS Next Y127.18%
EPS Next 2Y29.91%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue Next Year10.9%
Revenue Next 2Y7.39%
Revenue Next 3Y10.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CENX Yearly Revenue VS EstimatesCENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CENX Yearly EPS VS EstimatesCENX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.64, which indicates a correct valuation of CENX.
Based on the Price/Earnings ratio, CENX is valued cheaper than 89.61% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.51, CENX is valued rather cheaply.
A Price/Forward Earnings ratio of 10.95 indicates a reasonable valuation of CENX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CENX indicates a somewhat cheap valuation: CENX is cheaper than 75.32% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.58. CENX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.64
Fwd PE 10.95
CENX Price Earnings VS Forward Price EarningsCENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CENX is valued a bit cheaper than 72.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.37
CENX Per share dataCENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CENX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CENX's earnings are expected to grow with 62.41% in the coming years.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y29.91%
EPS Next 3Y62.41%

More info and screens

0

5. Dividend

5.1 Amount

CENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (7/14/2025, 8:00:00 PM)

After market: 20.77 +0.45 (+2.21%)

20.32

-0.39 (-1.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners58.85%
Inst Owner Change0%
Ins Owners0.95%
Ins Owner Change-0.16%
Market Cap1.90B
Analysts84.44
Price Target23.12 (13.78%)
Short Float %12.12%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.23%
Min EPS beat(2)-36.41%
Max EPS beat(2)7.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.83%
Min Revenue beat(2)7.6%
Max Revenue beat(2)20.06%
Revenue beat(4)3
Avg Revenue beat(4)9.29%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)20.06%
Revenue beat(8)6
Avg Revenue beat(8)7.05%
Revenue beat(12)7
Avg Revenue beat(12)4.28%
Revenue beat(16)8
Avg Revenue beat(16)2.39%
PT rev (1m)0%
PT rev (3m)-10.53%
EPS NQ rev (1m)-18.52%
EPS NQ rev (3m)-59.63%
EPS NY rev (1m)1.45%
EPS NY rev (3m)-2%
Revenue NQ rev (1m)2.43%
Revenue NQ rev (3m)-1.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.29%
Valuation
Industry RankSector Rank
PE 13.64
Fwd PE 10.95
P/S 0.8
P/FCF N/A
P/OCF 30.33
P/B 2.61
P/tB 2.61
EV/EBITDA 9.37
EPS(TTM)1.49
EY7.33%
EPS(NY)1.86
Fwd EY9.14%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.67
OCFY3.3%
SpS25.35
BVpS7.78
TBVpS7.78
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.8%
ROE 15.6%
ROCE 10.99%
ROIC 8.64%
ROICexc 8.9%
ROICexgc 8.9%
OM 7%
PM (TTM) 4.79%
GM 9.69%
FCFM N/A
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)3.31%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3Y6.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.18%
ROICexc growth 5YN/A
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
F-Score6
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA 1.86
Cap/Depr 89.35%
Cap/Sales 3.12%
Interest Coverage 4.36
Cash Conversion 25.18%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 0.63
Altman-Z 1.47
F-Score6
WACC9.94%
ROIC/WACC0.87
Cap/Depr(3y)115.12%
Cap/Depr(5y)92.4%
Cap/Sales(3y)3.72%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)282.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1300%
EPS Next Y127.18%
EPS Next 2Y29.91%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue 1Y (TTM)11.41%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%29.5%
Revenue Next Year10.9%
Revenue Next 2Y7.39%
Revenue Next 3Y10.44%
Revenue Next 5YN/A
EBIT growth 1Y2805.26%
EBIT growth 3Y20.15%
EBIT growth 5YN/A
EBIT Next Year219.85%
EBIT Next 3Y66.3%
EBIT Next 5YN/A
FCF growth 1Y86.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y634.19%
OCF growth 3YN/A
OCF growth 5YN/A